Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 66769-66770 [2010-27455]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
Dated: October 21, 2010.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2010–27330 Filed 10–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–D–0378]
Draft Compliance Policy Guide Sec.
690.800 Salmonella in Animal Feed;
Availability; Extension of Comment
Period
I. Background
In the Federal Register of August 2,
2010 (75 FR 45130), FDA published a
notice of availability of a draft CPG with
a 90-day comment period to request
comments on its proposal that certain
criteria should be considered in
recommending enforcement action
against animal feed or feed ingredients
that are adulterated due to the presence
of Salmonella. The Agency has received
a request for a 60-day extension of the
comment period for the draft CPG. The
request conveyed concern that the
current 90-day comment period does
not allow sufficient time to develop a
meaningful or thoughtful response to
the draft CPG. FDA has considered the
request and is extending the comment
period for the draft CPG for 60 days,
until December 31, 2010.
period.
The Food and Drug
Administration (FDA) is extending to
December 31, 2010, the comment period
for a notice of availability of a draft
compliance policy guide (CPG) that
appeared in the Federal Register of
August 2, 2010 (75 FR 45130). In the
document, FDA requested comments on
its proposal that certain criteria should
be considered in recommending
enforcement action against animal feed
or feed ingredients that are adulterated
due to the presence of Salmonella. The
Agency is taking this action in response
to requests for an extension to allow
interested persons additional time to
submit comments.
II. Request for Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments on this document. It is only
necessary to send one set of comments.
It is no longer necessary to send two
copies of mailed comments. Identify
comments with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
Dated: October 26, 2010.
Dara Corrigan,
Associate Commissioner for Regulatory
Affairs.
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; extension of comment
SUMMARY:
Submit either electronic or
written comments by December 31,
2010.
DATES:
Submit electronic
comments on the draft CPG to https://
www.regulations.gov. Submit written
comments on the draft CPG to the
Division of Dockets Management (HFA–
305), Food and Drug Administration,
5630 Fishers Lane, rm. 1061, Rockville,
MD 20852.
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
ADDRESSES:
Kim
Young, Center for Veterinary Medicine
(HFV–230), Food and Drug
Administration, 7519 Standish Pl.,
MPN–4, rm. 106, Rockville, MD 20855,
240–276–9200, e-mail:
Kim.young@fda.hhs.gov.
FOR FURTHER INFORMATION CONTACT:
SUPPLEMENTARY INFORMATION:
VerDate Mar<15>2010
15:23 Oct 28, 2010
Jkt 223001
[FR Doc. 2010–27448 Filed 10–28–10; 8:45 am]
BILLING CODE 4160–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting of the
aforementioned committee:
Board Public Meeting Times and Dates
(All Times Are Mountain Time)
8:15 a.m.–5:15 p.m., November 16,
2010.
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
66769
8:15 a.m.–5:15 p.m., November 17,
2010.
8:15 a.m.–12 p.m., November 18, 2010
Public Comment Times and Dates (All
Times Are Mountain Time)
5:30 p.m.–7 p.m.,* November 16,
2010.
5:30 p.m.–6:30 p.m.,* November 17,
2010.
*Please note that the public comment
periods may end before the times
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend public comment
sessions at the start times listed.
Place: Hilton Santa Fe Historic Plaza,
100 Sandoval Street, Santa Fe, New
Mexico; Phone: 505–988–2811; Fax:
505–986–6439. Audio Conference Call
via FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537 with
a pass code of 9933701.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 150
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program (EEOICP) Act of 2000 to advise
the President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2011.
Purpose: This Advisory Board is
charged with (a) Providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
E:\FR\FM\29OCN1.SGM
29OCN1
WReier-Aviles on DSKGBLS3C1PROD with NOTICES
66770
Federal Register / Vol. 75, No. 209 / Friday, October 29, 2010 / Notices
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Update and
Program Evaluation; Department of
Labor (DOL) Program Update;
Department of Energy (DOE) Program
Update; Los Alamos National
Laboratory Work Group Update; Board
Session to Discuss Evaluating Exposure
Potential for Radiological Materials in
Minor Quantities or Uses; SEC petitions
for: Linde Ceramics Plant (Tonawanda,
New York), General Electric Company
(Evendale, Ohio), Dow Chemical
(Madison, Illinois), Simonds Saw and
Steel Company (Lockport, New York),
Hangar 481 of Kirkland Airforce Base
(Albuquerque, New Mexico), BWX
Technologies (Lynchburg, Virginia), and
Texas City Chemicals Inc. (Texas City,
Texas); SEC Petition Status Updates;
SEC Class Definition Assessment
Report; Subcommittee and Work Group
Reports; and Board Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted in accordance with the
redaction policy provided below. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her name, no attempt will be made to
redact that name; (2) NIOSH will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
VerDate Mar<15>2010
15:23 Oct 28, 2010
Jkt 223001
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings; (3) If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
Information Act and the Federal
Advisory Committee Act and if deemed
appropriate, will redact such
information; (4) All disclosures of
information concerning third parties
will be redacted; and (5) If it comes to
the attention of the DFO that an
individual wishes to share information
with the Board but objects to doing so
in a public forum, the DFO will work
with that individual, in accordance with
the Federal Advisory Committee Act, to
find a way that the Board can hear such
comments.
Contact Person for More Information:
Theodore Katz, M.P.A., Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, NE., Mailstop E–20,
Atlanta, Georgia 30333, telephone: (513)
533–6800, toll free: 1 (800) CDC–INFO,
e-mail: ocas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
Notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
Dated: October 22, 2010.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2010–27455 Filed 10–28–10; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel, PA–07–030:
Program Project: Membrane Fusion.
Date: November 23, 2010.
Time: 11 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Nitsa Rosenzweig, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1102,
MSC 7760, Bethesda, MD 20892, (301) 435–
1747. rosenzweign@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 21, 2010.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–27325 Filed 10–28–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Clinical
Proteomic Technologies for Cancer Initiative
Research.
Date: December 13–15, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Adriana Stoica, PhD,
Scientific Review Officer, Special Review &
E:\FR\FM\29OCN1.SGM
29OCN1
]]>Agencies
[Federal Register Volume 75, Number 209 (Friday, October 29, 2010)]
[Notices]
[Pages 66769-66770]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-27455]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or Advisory
Board), National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), and pursuant to the requirements of 42
CFR 83.15(a), the Centers for Disease Control and Prevention (CDC),
announces the following meeting of the aforementioned committee:
Board Public Meeting Times and Dates (All Times Are Mountain Time)
8:15 a.m.-5:15 p.m., November 16, 2010.
8:15 a.m.-5:15 p.m., November 17, 2010.
8:15 a.m.-12 p.m., November 18, 2010
Public Comment Times and Dates (All Times Are Mountain Time)
5:30 p.m.-7 p.m.,\*\ November 16, 2010.
5:30 p.m.-6:30 p.m.,\*\ November 17, 2010.
\*\Please note that the public comment periods may end before the
times indicated, following the last call for comments. Members of the
public who wish to provide public comments should plan to attend public
comment sessions at the start times listed.
Place: Hilton Santa Fe Historic Plaza, 100 Sandoval Street, Santa
Fe, New Mexico; Phone: 505-988-2811; Fax: 505-986-6439. Audio
Conference Call via FTS Conferencing. The USA toll-free dial-in number
is 1-866-659-0537 with a pass code of 9933701.
Status: Open to the public, limited only by the space available.
The meeting space accommodates approximately 150 people.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program (EEOICP) Act of
2000 to advise the President on a variety of policy and technical
functions required to implement and effectively manage the new
compensation program. Key functions of the Advisory Board include
providing advice on the development of probability of causation
guidelines which have been promulgated by the Department of Health and
Human Services (HHS) as a final rule, advice on methods of dose
reconstruction which have also been promulgated by HHS as a final rule,
advice on the scientific validity and quality of dose estimation and
reconstruction efforts being performed for purposes of the compensation
program, and advice on petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2011.
Purpose: This Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose
[[Page 66770]]
reconstruction efforts performed for this program; and (c) upon request
by the Secretary, HHS, advise the Secretary on whether there is a class
of employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their radiation
dose, and on whether there is reasonable likelihood that such radiation
doses may have endangered the health of members of this class.
Matters To Be Discussed: The agenda for the Advisory Board meeting
includes: NIOSH Program Update and Program Evaluation; Department of
Labor (DOL) Program Update; Department of Energy (DOE) Program Update;
Los Alamos National Laboratory Work Group Update; Board Session to
Discuss Evaluating Exposure Potential for Radiological Materials in
Minor Quantities or Uses; SEC petitions for: Linde Ceramics Plant
(Tonawanda, New York), General Electric Company (Evendale, Ohio), Dow
Chemical (Madison, Illinois), Simonds Saw and Steel Company (Lockport,
New York), Hangar 481 of Kirkland Airforce Base (Albuquerque, New
Mexico), BWX Technologies (Lynchburg, Virginia), and Texas City
Chemicals Inc. (Texas City, Texas); SEC Petition Status Updates; SEC
Class Definition Assessment Report; Subcommittee and Work Group
Reports; and Board Work Sessions.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may be
submitted in accordance with the redaction policy provided below. Any
written comments received will be provided at the meeting and should be
submitted to the contact person below well in advance of the meeting.
Policy on Redaction of Board Meeting Transcripts (Public Comment):
(1) If a person making a comment gives his or her name, no attempt will
be made to redact that name; (2) NIOSH will take reasonable steps to
ensure that individuals making public comment are aware of the fact
that their comments (including their name, if provided) will appear in
a transcript of the meeting posted on a public Web site. Such
reasonable steps include: (a) A statement read at the start of each
public comment period stating that transcripts will be posted and names
of speakers will not be redacted; (b) A printed copy of the statement
mentioned in (a) above will be displayed on the table where individuals
sign up to make public comments; (c) A statement such as outlined in
(a) above will also appear with the agenda for a Board Meeting when it
is posted on the NIOSH Web site; (d) A statement such as in (a) above
will appear in the Federal Register Notice that announces Board and
Subcommittee meetings; (3) If an individual in making a statement
reveals personal information (e.g., medical information) about
themselves that information will not usually be redacted. The NIOSH
FOIA coordinator will, however, review such revelations in accordance
with the Freedom of Information Act and the Federal Advisory Committee
Act and if deemed appropriate, will redact such information; (4) All
disclosures of information concerning third parties will be redacted;
and (5) If it comes to the attention of the DFO that an individual
wishes to share information with the Board but objects to doing so in a
public forum, the DFO will work with that individual, in accordance
with the Federal Advisory Committee Act, to find a way that the Board
can hear such comments.
Contact Person for More Information: Theodore Katz, M.P.A.,
Designated Federal Officer, NIOSH, CDC, 1600 Clifton Road, NE.,
Mailstop E-20, Atlanta, Georgia 30333, telephone: (513) 533-6800, toll
free: 1 (800) CDC-INFO, e-mail: ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register Notices pertaining to
announcements of meetings and other committee management activities,
for both CDC and the Agency for Toxic Substances and Disease Registry.
Dated: October 22, 2010.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2010-27455 Filed 10-28-10; 8:45 am]
BILLING CODE 4163-18-P
